Facebook
Twitter
LinkedIn
Forward
Oncology 101: A Hematology and Oncology Primer for Advanced Practice Providers (On-Demand) Summer 2024
Oncology 101: A Hematology and Oncology Primer for Advanced Practice Providers - (On-Demand) Summer 2024
The demand for cancer care is expected to grow 40% over the next six years and ASCO is projecting a shortage of more than 2,200 oncologists by 2025. To meet the cancer care needs of patients, advanced practice providers (APPs), whose education and training is focused on health promotion, disease prevention, and primary care medical management, have increasingly been sought to fill the shortage. However, many APPs have little background or training in oncology. As a result, oncology practices need to provide new staff with an onboarding program that helps to establish a working baseline level of knowledge of hematology and oncology.
To help APPs prepare for a new career in the specialty of oncology, Horizon CME in partnership with APAO has developed “Oncology 101: A Hematology and Oncology Primer for Advanced Practice Providers”. In this on-demand program, clinicians will gain a basic understanding of cancer therapies, benign and malignant hematologic disorders, solid malignancies, supportive care strategies, oncologic emergencies, genetics and molecular testing, and more. Participation in this program will provide APPs with the foundational knowledge they need to provide support and care to cancer patients as part of the multidisciplinary oncology care team.
LEARNING OBJECTIVES:
Upon completion of this activity, participants should be better able to:
- Describe the presentation, evaluation, and treatment of common, solid, and hematologic malignancies
- Recognize the presentation, evaluation, and treatment of common benign hematologic disorders
- Summarize the role of genetics and molecular testing in cancer care
- Compare and contrast the various types of cancer treatment including stem cell transplant, chemotherapy, targeted therapies, radiotherapy, and immunotherapy
- Identify and appropriately manage common oncologic emergencies
- Outline the role of palliative care and effectively incorporate it into oncology practice
TARGET AUDIENCE:
This program is appropriate for new APPs, nurses, and pharmacists in oncology, clinicians seeking a review, or clinicians considering a career in oncology.
Presented By:
Commercial Support: This activity is supported in part by an independent medical education grant from Merck Sharp & Dohme LLC and Regeneron Pharmaceuticals, Inc.
(01) How to Build an APP Practice While Maximizing Productivity - 35:53 minutes (0.50 Credit)
» Heather Koniarczyk, MSN, APRN-CNP, AOCNP - Cleveland Clinic -Taussig Cancer Institute
(02) Immunotherapies - 48:26 minutes (0.75 Credit)
» Marianne Davies, DNP, ACNP, AOCNP, FAAN - Yale Comprehensive Cancer Center
(03) Pain Management in Cancer Care - 55:00 minutes (1.00 Credit)
» Matthew Robinson, DO, MS - University of Tennessee Health Science Center Administration and Services
(2-3) Stump the Faculty » Panel Q&A Discussion 13:43 minutes (0.25 Credit)
(04) Precision Medicine: The Role of Biomarker Testing in Cancer - 58:43 minutes (1.00 Credit)
» Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN - Cleveland Clinic
» Beth Sandy, MSN, CRNP - University of Pennsylvania
(05) Introduction to Malignant Hematology (1.75 Credit)
» Jennie M. Goble, PA-C - Mayo Clinic - 37:33 minutes (0.75)
» Lisa Nodzon PhD, APRN, AOCNP - Moffitt Cancer Center - 29:08 minutes (0.50)
» Maria (Rosie) Guerrero, DNP, NP-C, AOCNP - The University of Texas, MD Anderson Cancer Center - 19:29 minutes (0.25)
» Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN - Cleveland Clinic - 17:28 minutes (0.25)
(5) Stump the Faculty » Panel Q&A Discussion - 14:59 minutes (0.25 Credit)
(06) Chemotherapy Review - 70:58 minutes (1.25 Credit)
» Sandra Cuellar, PharmD, BCOP, FHOPA, FASHP - University of Illinois College of Pharmacy
(07) Introduction to Benign Hematology (1.50 Credit)
» Peter Hakos, PA-C - Clevelan Clinic - 42:09 minutes (0.75)
» Lauren Imboden, PA-C - Atrium Health Wake Forest Baptist - 47:33 minutes (0.75)
(08) Introduction to Allogeneic Stem Cell Transplantation - 31:26 minutes (0.50 Credit)
» Christina Ferraro, CNP - Cleveland Clinic
(7-8) Stump the Faculty » Panel Q&A Discussion- 10:11 minutes (0.25 Credit)
(09) CAR-T Cell Therapy - 29:21 minutes (0.50 Credit)
» Patricia Mangan, RN, MSN, CRNP - University of Pennsylvania
(10) The Basics of BiSpecifcs - 29:42 minutes (0.50 Credit)
» Ellen Marin, PA-C - Winship Cancer Institute of Emory University
(11) Difficult Conversations and End of Life Care - 42:28 minutes (0.75 Credit)
» Justin Baker, MD - St. Jude Children's Research Hospital
(9-11) Stump the Faculty » Panel Q&A Discussion - 16:23 minutes (0.25 Credit)
(12) Introduction to Solid Malignancies - Part 1 (2.00 Credit)
» Jamie Carroll, APRN, CNP, MSN - Mayo Clinic - 33:50 minutes (0.50)
» Beth Sandy, MSN, CRNP - University of Pennsylvania - 25:39 minutes (0.50)
» Kathleen Boyle, DScPAS, PAC - Dana-Farber Cancer Institute - 26:04 minutes (0.50)
» Jessica Walchonski, PA-C - UCLA Health - 20:47 minutes (0.25)
» Grace Baek, PharmD, BCOP - Fred Hutchinson Cancer Center - 19:41 minutes (0.25)
(12) Stump the Faculty » Panel Q&A Discussion - 13:02 minutes (0.25 Credit)
(13) Targeted Therapies - 47:47 minutes (0.75 Credit)
» Jennifer Murphy, PharmD, BCOP - UCD Health, Oncology, and Investigational Drug Service
(14) Oncologic Emergencies - 29:29 minutes (0.50 Credit)
» Meredith Beaton, MSN, RN, AG-ACNP - UCHealth Anschutz
(13-14) Stump the Faculty » Panel Q&A Discussion - 10:58 minutes (0.25 Credit)
(15) Cancer Survivorship - 39:04 minutes (0.50 Credit)
» Todd Hultman, PhD, ACNP, ACHPN - Presbyterian Healthcare Services
(16) Introduction to Solid Malignancies – Part 2 (0.75 Credit)
» Laura S. Wood, RN, MSN, OCN - Cleveland Clinic - 16:20 minutes (0.25)
» Michael Lai, ARNP - Fred Hutchinson Cancer Center - 33:07 minutes (0.50)
(17) Supportive Care - 60 minutes (1.00 Credit)
» Laura J. Zitella, MS, RN, ACNP-BC, AOCN - Hematology/Oncology Nurse Practitioner
(15-17) Stump the Faculty » Panel Q&A Discussion - 12:00 minutes (0.25 Credit)
Planning Committee
Beth Faiman, PHD, MSN, APN-BC, AOCN, BMTCN, FAAN
Nurse Practitioner
Department of Hematology and Medical Oncology Cleveland Clinic
Cleveland, OH
Beth Sandy, MSN, CRNP
Nurse Practitioner, Thoracic Medical Oncology
Abramson Cancer Center, University of Pennsylvania
Philadelphia, PA
Val R. Adams, PharmD, FCCP, FHOPA, BCOP
Associate Professor, Oncology Specialist
University of Kentucky
Lexington, KY
Faculty
Justin Baker, MD
Chief, Division of Quality of Life and Palliative Care
Stanford School of Medicine
Stanford, CA
Marianne Davies, DNP, ACNP, AOCNP, FAAN
Nurse Practitioner
Yale Comprehensive Cancer Center
New Haven, CT
Laura J. Zitella, MS, RN, ACNP-BC, AOCN
Associate Clinical Professor
University of California San Francisco
Hematology/Oncology Nurse Practitioner
San Francisco, CA
Jennie M. Goble, PA-C
Instructor in Medicine
Mayo Clinic
Rochester, MN
Jamie Carroll APRN, CNP, MSN
Nurse Practitioner
Mayo Clinic
Rochester, MN
Matthew Robinson DO, MS
Attending Physician
Associate Medical Director of Hospice Baptist Memorial Hospital
Memphis, TN
Lauren Imboden, MMS, PA-C
Physician Assistant
Atrium Health Wake Forest Baptist
Winston Salem, NC
Ellen Marin, PA-C
Physician Assistant
Winship Cancer Institute of Emory University
Atlanta, GA
Christina Ferraro, CNP
Nurse Practitioner
Cleveland Clinic
Cleveland, OH
Meredith Beaton, MSN, RN, AG-ACNP
Nurse Practitioner
UCHealth Anschutz
Aurora, CO
Todd Hultman, PhD, ACNP, ACHPNDNP
Nurse Practitioner Specialist
Presbyterian Healthcare Services
Northern New Mexico
Kathleen Boyle, DScPAS, PA-C
Physician Assistant
Dana-Farber Cancer Institute
Boston, MA
Heather Koniarczyk, MSN, APRN-CNP, AOCNP
Adult Nurse Practitioner
Cleveland Clinic -Taussig Cancer Institute
Cleveland, OH
Jessica Walchonski, PA-C
Physician Assistant
UCLA Health
Los Angeles, CA
Grace Baek, PharmD, BCOP
Clinical Pharmacist, Hematology/Oncology
Fred Hutchinson Cancer Center
Seattle, WA
Sandra Cuellar, PharmD, BCOP, FHOPA, FASHP
Clinical Oncology Pharmacist
University of Illinois College of Pharmacy
Chicago, IL
Jennifer Murphy, PharmD, BCOP
Senior Pharmacist
UCD Health, Oncology, and Investigational Drug Service
San Francisco, CA
Laura Wood, RN, MSN, OCN
Nurse
Cleveland Clinic, Taussig Cancer Center
Cleveland, OH
Michael Lai, ARNP
Nurse Practitioner
Fred Hutchinson Cancer Center
Seattle, WA
Lisa Nodzon PhD, APRN, AOCNP
Nurse Practitioner
H. Lee Moffitt Cancer Center and Research Institute
Tampa, FL
Patricia Mangan, RN, MSN, CRNP
Nurse Lead, Hematologic Malignancies Program
Abramson Cancer Center,
University of Pennsylvania
Philadelphia, PA
Maria (Rosie) Guerrero, DNP, NP-C, AOCNP
Nurse Practitioner
The University of Texas, MD Anderson Cancer Center
Austin, TX
DISCLOSURES:
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, prior to an activity, Horizon CME requires all planners, faculty, and other contributors to disclose any financial relationships with an ACCME defined ineligible company within the past 24 months and Horizon CME has resolved any conflicts prior to this educational activity.
Faculty, Authors, and Content Developers Disclosures:
- Matthew Robinson, DO, MS discloses contracted research with American Osteopathic Association during the past 24 months.
- Beth Sandy, MSN, CRNP discloses Speaker’s Bureau with Lilly, Amgen, AstraZeneca, Takeda, Jazz, Merck and Consulting Fee with Janssen during the past 24 months.
- Lisa Nodzon PhD, APRN, AOCNP discloses Speaker’s Bureau with Pharmacyclics AstraZeneca and Speaker’s Bureau with Takeda and Genentech/AbbVie but that relationship has ended.Advisory Board with BeiGene; Pharmacyclics, Novartis and Consulting Fee with AstraZeneca; AbbVie during the past 24 months.
- Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN discloses Advisory Board and Consulting Fee with Janssen, Sanofi, Karyopharm during the past 24 months.
- Sandra Cuellar, PharmD, BCOP, FHOPA, FASHP discloses Speaker’s Bureau with Mirati and Advisory Boards with Genentech during the past 24 months.
- Peter Hakos, PA-C discloses owning stocks with Pfizer, AbbVie during the past 24 months.
- Patricia Mangan, RN, MSN, CRNP discloses Speaker’s Bureau and Advisory Boards with BMS and Janssen, but that relationship has ended during the past 24 months.
- Jamie Carroll, APRN, CNP, MSN discloses Advisory Board Pfizer,Novartis, Sermonix, Eli Lilly, AstraZeneca and Consulting Fee with Research to practice but all of these relationships have ended during the past 24 months.
- Jessica Walchonski, PA-C discloses Advisory Boards with Immunogen but that relationship has ended during the past 24 months.
- Jennifer Murphy, PharmD, BCOP discloses Speaker’s Bureau with McCreadie but that relationship has ended and Ownership interest with AbbVie, Moderna during the past 24 months.
- Laura S. Wood, RN, MSN, OCN discloses Speaker’s Bureau with AVEO, BMS, EMD Serono, Exelixis, Merck, Pfizer during the past 24 months.
- Michael Lai, ARNP discloses Advisory Boards with Janssen, Bayer, Astellas, Seagen but these relationships have ended during the past 24 months.
- Laura J. Zitella, MS, RN, ACNP-BC, AOCN discloses BeiGene, ABbvie but both relationships have ended during the past 24 months.
Planners:
- Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN discloses Advisory Board and Consulting Fee with Janssen, Sanofi, Karyopharm during the past 24 months.
- Val R. Adams, PharmD, FCCP, FHOPA, BCOP discloses contracted research with BMS but that relationship has ended during the past 24 months.
- Beth Sandy, MSN, CRNP discloses Speaker’s Bureau with Lilly, Amgen, AstraZeneca, Takeda, Jazz, Merck and Consulting Fee with Janssen during the past 24 months.
Those others involved in the planning of this activity disclosed no relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Other Contributors
All other non-faculty contributors and others involved in the planning, development and editing/review of the content disclosed no relevant financial relationships with any entity producing, marketing, re-selling or distributing health care goods or services consumed by or used on patients.
Copyright Information
Copyright© 2024 by Horizon CME. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from Horizon CME.
Available Credit
- 17.25 AMA PRA Category 1 Credit™Horizon CME designates this Enduring activity for a maximum of 17.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 17.25 ANCCThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 17.25 credit.
- 3.25 PharmacologyThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 3.25 credit.
Price
Required Hardware/software
Access to the internet is required.
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above